BRCA2 and breast cancer: Two large meta-analyses report worse overall survival for both [14,15] when compared to sporadic BC, whereas two other large meta-analyses concluded worse overall survival only for BRCA1 patients, with similar overall survival for BRCA2 patients [16,17].